European Laboratory Research & Innovation Group PROGRAMME OF EVENTS.

Transcription

1 European Laboratory Research & Innovation Group PROGRAMME OF EVENTS

2 WHO ARE WE? WORLD CLASS MEETINGS & CONFERENCES ELRIG is a UK-based not-for-profit organisation. We are a leader in scientific meetings and conferences, bringing together experts from industry, academic and biopharma experts and thought leaders to exchange ideas and information. Our events are tailored to address the changing needs of the drug discovery and life science communities and can now be found throughout the UK and in multiple countries across Europe. Our flagship event, Drug Discovery, has attracted over 1,300 delegates in previous years, making it the biggest conference of its kind in Europe. OUR MISSION ELRIG was founded based on the use and broad applications of automation, robotics and instrumentation in life science laboratories. Today, we have grown and now cover a broad range of science and technology areas including drug discovery, assay development and screening, high throughput technologies, diagnostics and biomarkers, and bioinformatics. Our scientific meetings and conferences highlight the newest research and state-of-theart technology advancement sacross a broad range of scientific disciplines. To support our open access claims, we provide free-of-charge delegate access to all ELRIG meetings. HIGH IMPACT NETWORKING EVENTS Over 7,000 members across UK & Europe Delegates from academia and biopharma Multi-track scientific sessions Poster presentations Technology forums Vendor exhibitions Job fairs UNPARALLELED SCIENTIFIC PROGRAMS Drug Discovery Assay Development & Screening Robotics & Automation Recombinant Protein Technology Flow Cytometry & Imaging Next Generation Sequencing Stem Cells & Regenerative Medicine Diagnostics & Biomarkers Mass Spectrometry More recently, we have responded to the needs of biopharma by developing scientific programs that focus on cutting-edge research areas like primary cell models and phenotypic screening that have the potential to revolutionize drug discovery. OUR EVENTS We believe that meetings and conferences should be accessible to all. In order to meet our open access claims, we provide free-ofcharge access to all delegates and aim to cover the cost of staging our events through the contributions of the exhibitors and sponsors. We also support an open policy of collaboration with other well-established and respected professional societies to add both breadth and depth to our offering.

3 THE WORLD OF DRUG DISCOVERY IS CHANGING ELRIG Events Programme brings together multiple hot topical areas in the world of early drug discovery and addresses the challenges facing them. Join us at one or more of our five events to hear leading experts in industry and academia discuss cutting edge research and technologies. Recombinant Protein Technology Robotics & Automation Learn about innovative components and technologies used in laboratory robotics & automation applications Research & Innovation As new advances in cell biology can improve the success of drug discovery, hear case studies about industry updates and lessons learned. Gain a deeper understanding of recent innovations in host cell factory & protein engineering and what this means for discovery and novel therapeutic development Drug Discovery Attend our 10th anniversary celebration and explore the latest scientific breakthroughs and network with industry experts developing innovative technologies to advance drug discovery. Pharmaceutical Flow Cytometry & Imaging Identify best practices in applying new techniques and applications of flow cytometry & imaging systems from discovery research to clinical evaluation. ELRIG EVENTS

4 Research & Innovation TRENT VINEYARD, NOTTINGHAM 23 rd March #ELRIGRI16 CONFERENCE OVERVIEW The theme of the conference is Back to Biology. This single day, multi-track meeting will bring together world class speakers and leading industry experts who will discuss the challenges and opportunities in developing and applying new thinking across biology to improve the success of drug discovery. Two main areas of focus will be Cell Biology & Biologics and presentations will explore how to apply new innovations in these fields to improve the success of drug discovery. This conference will be organized into three tracks: Biopharmaceutical Agents, Stem Cell Biology, and Synthetic Biology. We are expanding the conference meeting this year to include a complementary technology symposium called Innovation in Mass Spectrometry. CONFERENCE DIRECTORS Mark Wigglesworth Director High Throughput Screening AstraZeneca, Alderley Park Mike Jowett Manager, Product Support, Illumina PLENARY KEYNOTE PRESENTATION Stephen Ward COO, Cell Therapy Catapult

5 Robotics & Automation FESTO, NORTHAMPTON 4 th May #ELRIGRA16 CONFERENCE OVERVIEW The Research & Automation meeting, located at the innovative FESTO Applied Automation UK headquarters in Northampton, will focus on the components and technologies used in laboratory automation applications. This single day, single track meeting provides a unique opportunity to hear about the latest advances in automation and network with colleague and suppliers to discuss the latest trends. This conference is ideal for researchers in life sciences laboratories and who want to learn more about automation and would benefit from the implementation of these technologies. The scientific programme will cover a diverse range of topics including software for the automated process (control & data), robotic and process simulation and automation tools (vision and transportation). A tour of the facility will also be provided as well as a sneak peak at some of the latest FESTO innovations. CONFERENCE DIRECTORS Paul Harper Associate Principal Scientist Screening Sciences, AstraZeneca, Alderley Park Malcolm Crook Director, PAA Paul Kendall Business Development Manager, FESTO Ltd

6 Recombinant Protein Technology ASTRAZENECA, M LNDAL, SWEDEN 8 th - 9 th June #ELRIGRPT16 CONFERENCE OVERVIEW The Recombinant Protein Technology meeting will be held for a second time at the AstraZeneca campus in Gothenburg, Sweden. The meeting will focus on the latest advances in technologies for the design and production of recombinant proteins used as biotherapeutics and as reagents in drug discovery. In particular, the conference will focus on the biology of existing host (with respect to their competency for protein expression) and how both host cell and desired proteins may be engineered to generate new systems for enhanced product expression. During this two day conference, researchers from top academic and industrial laboratories will discuss the current understanding of molecular events that determine quality and productivity and the use of specific cell hosts for particular types of protein product. Presentations will cover developments in the following crucial areas in meeting future demands for recombinant proteins in drug discovery: host cell factories, genome editing, and protein engineering: novel proteins and peptide. CONFERENCE DIRECTORS Alan Dickson Professor of Biotechnology Director, Centre of Excellence in BioPharmaceuticals Co-Director, BioProNET Manchester University Katy Gearing Director, GlaxoSmithKline Robert Roth Associate Principal Scientist, AstraZeneca, Mölndal

7 Drug Discovery ACC, LIVERPOOL 13th - 14th October #ELRIGDD16 CONFERENCE OVERVIEW The 10th Anniversary celebration of Drug Discovery will be held this year in Liverpool at the Echo Arena and will once again will bring together the leading lights in drug discovery research across pharma, biotech, academia and the vendor community. The meeting will feature over 50 invited speakers in 6 main session tracks, each highlighting the latest scientific breakthroughs and new approaches that are driving this success. Scientific tracks will cover therapeutic areas (e.g. oncology & immunotherapy), innovative technologies (e.g. assay development, screening, chemistry), and target progression challenges (e.g. target identification/validation, translational models). New to this year, we also introduce a track where ground breaking developments in the use of cells as biological tools and therapeutics will be discussed. CONFERENCE DIRECTORS Rachel Grimley Director, GlaxoSmithKline Del Tresize Director and European Site Head, Essen Bioscience Chas Bountra Professor, Structural Genomics Consortium, Oxford University

8 Pharmaceutical Flow Cytometry & Imaging GLAXOSMITHKLINE, STEVENAGE 22 nd - 23 rd November #ELRIGFC16 CONFERENCE OVERVIEW The 4th annual Pharmaceutical Flow Cytometry & Imaging meeting will be held at the GlaxoSmithKline, Stevenage, UK. This meeting continues to be the ideal forum for users of Flow Cytometry & imaging systems within drug discovery and drug development to get together, share expertise and innovation, and discuss pitfalls, successes and ideas for the future. The scientific programme will once again include topics of current interest and encourage discussion of the changing face of drug discovery. This year, presentations will explore the use of flow cytometry and imaging for high throughput / high content screening, biopharmaceutical drug development, safety and secondary pharmacology, biomarker validation, phenotypic screening and disease modeling using stem cells. CONFERENCE DIRECTORS Ben Powney Team Leader - Scientist, Eisai Beverley Isherwood Associate Director, AstraZeneca James Pilling Associate Principal Scientist, AstraZeneca Rob Jepras Investigator, GlaxoSmithKline

9 WHY EXHIBIT AT AN ELRIG EVENT? Launch new products and services Keep up to date with industry trends Network with qualified prospects Target influential decision makers Generate new sales leads WHO ATTENDED DRUG DISCOVERY 2015? Research / Staff Scientist Director / Mid Level Manager CEO / President / Founder Student / Post Doc Manager / Partner / MD Co-ordinator / Admin Vice President / General Manager Chief Officer (CMO, CIO etc.) Faculty / Professor 31% 22% 19% 10% 9% 3% 2% 2% 2% DELEGATE SEGMENTATION BY INDUSTRY (%) 31% Biotech 38% Academia 20% 5% Marketing & Consulting 6% Other Pharma GEOGRAPHICAL ATTENDEE BREAKDOWN* UK 81% Rest of Europe 13.5% USA 3% Rest of World 2.5% * taken as a % of delegates who specified a country of origin

10 ELRIG SPONSORSHIP OPPORTUNITIES Sponsorship Benefit Standard Bronze Silver Gold Platinum Standard Exhibition Booth Poster Name and logo in event programme Logo with link on ELRIG website Standard five minute snapshot to full auditorium Literature bag insert / Chair drop Premium booth space 30 minute podium presentation Booth Price for event: Research & Innovation 2,000 2,250 2,750 4,250 10,000 Robotics & Automation 2,000 2,250 2,750 4,250 10,000 Recombinant Protein Technology 2,250 2,500 3,000 4,500 10,000 Drug Discovery 3,250 3,500 4,000 5,500 10,000 Pharmaceutical Flow Cytometry & Imaging 2,250 2,500 3,000 4,500 10,000 FURTHER SPONSORSHIP OPPORTUNITIES ELRIG offer a number of other networking reception and bespoke sponsorship opportunities which can be tailored to meet your needs. These include: Speaker dinner Scientific track Lunch service Tea/Coffee service Networking reception Drinks reception Poster session Banner stand in lunch area Wi-Fi Sponsorship To discuss any of these opportunities, contact us on: info@elrig.org

11 MEDIA PACK Advertising with ELRIG is an excellent way for your organisation to reach a targetted market within the life sciences community. We can help you engage with both existing and prospective customers in the field of science, research, engineering and business in a variety of different ways to help you to achieve your marketing objectives. (All prices shown are for a 30 day advertising slot.) NEWSLETTER The ELRIG newsletter is ed directly to a opt-in list of over The list comprises a geographical subscribers breakdown of 85% UK, 8% mainland Europe and 2% US /other. There is a less than 0.4% attrition rate and our list is growing. Every attendee of an ELRIG event is added to the mailing list at registration and each event adds several hundred new contacts. We offer either a horizontal or vertical advert space to suit your graphics: WEBSITE On average, the ELRIG website receives page views per month and is where we publish updates about our events, speakers and exhibitors as well as giving access to the latest news, event registration and newsletter subscription. Research & Innovation TRENT VINEYARD, NOTTINGHAM 23 rd March Newsletter February Preliminary Agenda just announced Research & Innovation Trent Vineyard, Nottingham, UK Research & Innovation TRENT VINEYARD, NOTTINGHAM 23 rd March x 220px ADVERTISING GUIDELINES Newsletter February Preliminary Agenda just announced Research & Innovation Trent Vineyard, Nottingham, UK Research & Innovation Horizontal advert TRENT VINEYARD, NOTTINGHAM 23 rd March x 600px w:240 x h:120 px w:520 x h:120 px w:800 x h:120 px w:1100 x h:120 px Vertical advert All web or newsletter advertising material should be sent in standard jpeg format at a resolution of 300 dpi. No Flash or animation files please. For links, please supply full URL of the target page. For any rollover / alt tags, please supply text content. All content should be provided in an HTML file with images attached separately in jpeg format at a resolution of 300 dpi.

12 GET SOCIAL! Follow us on Follow us on Facebook: Connect on Linked In: ELRIG MOBILE APP Get the ELRIG mobile app by scanning the QR code below or downloading the app: ELRIG NEWSLETTER Subscribe to our free newsletter to receive regular updates about our meetings by visiting: SOME PREVIOUS ELRIG EXHIBITORS: